MedApp S.A
MedApp S.A operates in Application Software.
MedApp S.A (MDA) - Net Assets
Latest net assets as of June 2024: zł26.09 Million PLN
Based on the latest financial reports, MedApp S.A (MDA) has net assets worth zł26.09 Million PLN as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł36.33 Million) and total liabilities (zł10.24 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł26.09 Million |
| % of Total Assets | 71.82% |
| Annual Growth Rate | 36.08% |
| 5-Year Change | 64.69% |
| 10-Year Change | N/A |
| Growth Volatility | 68.54 |
MedApp S.A - Net Assets Trend (2018–2023)
This chart illustrates how MedApp S.A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MedApp S.A (2018–2023)
The table below shows the annual net assets of MedApp S.A from 2018 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | zł26.73 Million | -1.68% |
| 2022-12-31 | zł27.19 Million | +7.70% |
| 2021-12-31 | zł25.25 Million | +22.81% |
| 2020-12-31 | zł20.56 Million | +26.65% |
| 2019-12-31 | zł16.23 Million | +183.29% |
| 2018-12-31 | zł5.73 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to MedApp S.A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 547631049.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | zł26.72 Million | 111.17% |
| Total Equity | zł24.04 Million | 100.00% |
MedApp S.A Competitors by Market Cap
The table below lists competitors of MedApp S.A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Solar Philippines Nueva Ecija Corp
PSE:SPNEC
|
$207.05 |
|
CRAFTPORT CANNABIS CORP.
F:BBW0
|
$207.26 |
|
First Helium Inc
OTCQB:FHELF
|
$207.47 |
|
Belle Corp
PSE:BEL
|
$207.65 |
|
El Kahera Housing
EGX:ELKA
|
$206.31 |
|
EPE Special Opportunities Limited
LSE:ESO
|
$206.21 |
|
AFRICAN DISTILLERS LIMITED
XZIM:AFDS
|
$205.98 |
|
Roquefort Investments PLC
LSE:ROQ
|
$204.19 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MedApp S.A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 27,190,000 to 24,039,000, a change of -3,151,000 (-11.6%).
- Net loss of 3,127,000 reduced equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł-3.13 Million | -13.01% |
| Other Changes | zł-24.00K | -0.1% |
| Total Change | zł- | -11.59% |
Book Value vs Market Value Analysis
This analysis compares MedApp S.A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.95x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 2.21x to 0.95x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | zł0.04 | zł0.09 | x |
| 2019-12-31 | zł0.07 | zł0.09 | x |
| 2020-12-31 | zł0.08 | zł0.09 | x |
| 2021-12-31 | zł0.10 | zł0.09 | x |
| 2022-12-31 | zł0.11 | zł0.09 | x |
| 2023-12-31 | zł0.10 | zł0.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MedApp S.A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -13.01%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -54.52%
- • Asset Turnover: 0.16x
- • Equity Multiplier: 1.49x
- Recent ROE (-13.01%) is below the historical average (-3.71%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -41.27% | -1910.63% | 0.01x | 2.24x | zł-2.94 Million |
| 2019 | 4.15% | 20.87% | 0.17x | 1.16x | zł-950.04K |
| 2020 | 9.32% | 31.79% | 0.26x | 1.13x | zł-140.52K |
| 2021 | 16.33% | 32.44% | 0.39x | 1.29x | zł1.60 Million |
| 2022 | 2.24% | 9.05% | 0.21x | 1.18x | zł-2.11 Million |
| 2023 | -13.01% | -54.52% | 0.16x | 1.49x | zł-5.53 Million |
Industry Comparison
This section compares MedApp S.A's net assets metrics with peer companies in the Software & IT Services industry.
Industry Context
- Industry: Software & IT Services
- Average net assets among peers: $36,762,478
- Average return on equity (ROE) among peers: -60.73%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MedApp S.A (MDA) | zł26.09 Million | -41.27% | 0.39x | $206.39 |
| Draw Distance SA (DDI) | $2.96 Million | -14.24% | 2.85x | $344.22 |
| Eonet (EON) | $30.83 Million | 2.67% | 0.37x | $66.34K |
| HubStyle S.A. (HUB) | $187.12 Million | 6.77% | 0.78x | $607.78 |
| Jujubee SA (JJB) | $1.16 Million | 23.80% | 1.22x | $1.67K |
| Makolab (MLB) | $25.82 Million | 8.42% | 0.43x | $18.87K |
| NGG (NGG) | $2.27 Million | -580.53% | 0.86x | $66.69 |
| Pointpack.pl S.A. (PNT) | $10.39 Million | 48.66% | 1.07x | $29.58K |
| Softblue SA (SBE) | $67.82 Million | 5.35% | 0.18x | $426.76 |
| THD (THD) | $2.50 Million | -47.46% | 0.67x | $1.91K |